Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis. (2007). Reumatismo, 59(1), 32-37. https://doi.org/10.4081/reumatismo.2007.32